Biologistics World Korea
By 2020, it is predicted 60 percent of the top 100 healthcare products will be biotech and estimate 8 of the top 10 best-selling global drugs will require handling at +2oC to +8oC. Managing the transportation of temperature-controlled products (refrigerated and frozen) will total $12.6 billion this year, continuing an 8–9% per year growth rate that is roughly double that of pharma products overall.
Biologistics World Korea is the MOST Targeted event that focuses on supply chain management and logistics for biologics and vaccines. The conference aims to provide insights on key challenges. If this is something that interests you, download the brochure below!
Biologistics World Korea will be the only dedicated conference in Asia that will attract all the biopharma players to discuss and debate on best practices, challenges, and innovations in this space. Be part of it!
Korean government proposes to become the seventh-largest of the total global market by 2020. According to a report by GlobalData, Korea’s Biopharmaceutical market is expected to rise to reach $20.4 billion in value by 2020. Korea’s biopharmaceutical market is worth about $2.3 billion in 2017, accounting for 12.8% share of Korea’s pharmaceutical market worth $18.0 billion as of 2017. (Source: MFDS Yearbook 2018)